What are the best treatments for Hypophosphatasia?

The primary treatment for Hypophosphatasia is enzyme replacement therapy using asfotase alfa (Strensiq), which is designed to replace the missing or dysfunctional alkaline phosphatase enzyme. Beyond this, management of Hypophosphatasia focuses on a multidisciplinary approach involving orthopedic, dental, and rehabilitative care to address the specific skeletal and dental manifestations of the condition.

What are the primary medical treatments for Hypophosphatasia?

The current gold-standard medical therapy for Hypophosphatasia is enzyme replacement therapy. Asfotase alfa (Strensiq) is a recombinant human tissue-nonspecific alkaline phosphatase that helps to normalize bone mineralization and improve respiratory and motor function in patients with pediatric-onset disease. Because Hypophosphatasia is a systemic condition, this medication is typically administered via subcutaneous injection. It is important to note that treatment plans must be highly personalized by a metabolic specialist, as the severity of Hypophosphatasia ranges from lethal perinatal forms to milder adult-onset presentations, and not all patients require the same therapeutic approach.

What non-pharmacological interventions are used for Hypophosphatasia?

Because Hypophosphatasia affects bone health, teeth, and muscle strength, a comprehensive management plan often includes non-pharmacological support to improve quality of life and functional independence. Patients often work with a team of allied health professionals to mitigate the impact of skeletal fragility and dental issues. Key supportive interventions include:

• Physical Therapy: Essential for improving muscle strength, gait, and mobility, especially in patients experiencing chronic bone or joint pain.


• Occupational Therapy: Focuses on adapting daily tasks to protect joints and manage fatigue related to Hypophosphatasia.


• Orthopedic Care: Specialized surgical intervention may be required to manage fractures, pseudofractures, or craniosynostosis (premature fusion of skull bones).


• Dental Management: Regular monitoring by a pediatric dentist or periodontist is critical, as premature loss of primary teeth is a hallmark of Hypophosphatasia.

Which specialists should be on a Hypophosphatasia care team?

Managing Hypophosphatasia effectively requires a multidisciplinary care team, as the disease can affect multiple body systems simultaneously. A patient’s care team should ideally include:

1. Metabolic Geneticist or Endocrinologist: To manage enzyme replacement therapy and oversee metabolic markers.


2. Orthopedic Surgeon: To monitor skeletal integrity and handle surgical needs.


3. Dentist/Periodontist: To address premature tooth loss and periodontal health.


4. Physical/Occupational Therapist: To maintain physical function and adaptive independence.


5. Clinical Geneticist: To provide genetic counseling for the patient and their family members.

Are there emerging treatments for Hypophosphatasia?

Research into Hypophosphatasia is highly active. Beyond current enzyme replacement therapies, clinical researchers are investigating gene therapies and alternative delivery methods for enzyme replacement to improve patient outcomes. Participation in clinical trials remains a vital way for the community to contribute to the understanding of the disease. At DiseaseMaps.org, we have seen 9 individuals with Hypophosphatasia share their lived experiences, which helps researchers better understand the heterogeneous nature of the condition and how treatment effectiveness varies from one individual to another.

Next steps

• Consult with a metabolic specialist or endocrinologist to discuss if enzyme replacement therapy is appropriate for your specific case.


• Request a referral to a physical therapist experienced in rare metabolic bone diseases.


• Connect with the DiseaseMaps community to share experiences and learn from others living with Hypophosphatasia.


• Register with official rare disease registries to stay informed about upcoming clinical trials and research breakthroughs.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your physician for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hypophosphatasia.


• Orphanet: Hypophosphatasia (ORPHA:418).


• Online Mendelian Inheritance in Man (OMIM): Hypophosphatasia (#146300).


• The MAGIC Foundation: Hypophosphatasia Support and Resources.